Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Osimertinib.
Recent Results Cancer Res. 2018;211:257-276. doi: 10.1007/978-3-319-91442-8_18.
Recent Results Cancer Res. 2018.
PMID: 30069773
Review.
The safety of nivolumab for the treatment of advanced non-small cell lung cancer.
Metro G, Ricciuti B, Brambilla M, Baglivo S, Soli I, Minenza E, Leonardi GC, D'arpino A, Colabrese D, Tazza M, Zicari D, Minotti V, Chiari R.
Metro G, et al. Among authors: tazza m.
Expert Opin Drug Saf. 2017 Jan;16(1):101-109. doi: 10.1080/14740338.2017.1267725. Epub 2016 Dec 11.
Expert Opin Drug Saf. 2017.
PMID: 27910704
Review.
Item in Clipboard
Optimal management of ALK-positive NSCLC progressing on crizotinib.
Metro G, Tazza M, Matocci R, Chiari R, Crinò L.
Metro G, et al. Among authors: tazza m.
Lung Cancer. 2017 Apr;106:58-66. doi: 10.1016/j.lungcan.2017.02.003. Epub 2017 Feb 6.
Lung Cancer. 2017.
PMID: 28285695
Review.
Item in Clipboard
Adjuvant treatment of non-small cell lung cancer: focus on targeted therapy.
Tazza M, Metro G.
Tazza M, et al.
J Thorac Dis. 2017 Oct;9(10):4064-4069. doi: 10.21037/jtd.2017.08.130.
J Thorac Dis. 2017.
PMID: 29268417
Free PMC article.
Review.
Item in Clipboard
Cite
Cite